Abstract
Ventilator-associated pneumonia (VAP) is defined as pneumonia occurring in a patient after intubation with an endotracheal tube or tracheostomy tube lasting for 48 hours or more. We describe a case of 75-year-old male who initially presented with pneumonia of the right basis with accompanying plevritis. The patient was intubated and his condition was complicated with a VAP infection while he developed a lung abscess. The antibiotic therapy was based on susceptibility bronchial secretions isolated acinetobacter baumannii and klebsiella pneumoniae; these pathogens were also isolated from the drained abscess. The patient was discharged in good health. The interest of this case is recommended in the existence of two responsible pathogens, the paucity of the development of lung abscess in a patient with VAP, and the successful treatment of the patient with the combination of controlled drainage of the abscess and appropriate antibiotic therapy.
Highlights
Ventilator-associated pneumonia (VAP) is a common, possibly life-threatening complication in intensive care unit (ICU) patients with a reported relative risk of 9-27% and mortality of 25-50% [1].The pathogenesis of VAP is supported to initiate from the aspiration of oropharyngeal secretions past the endotracheal tube cuff or from inoculation directly into the airway, resulting in the development of severe inflammationManuscript accepted for publication September 14, 2012We present an extremely rare case of a patient with VAP who developed lung abscess, due to acinetobacter baumanii infection and who was treated with administration of mereponem and colistin combined with computed tomography (CT)-guided drainage
Ventilator-associated pneumonia (VAP) is defined as pneumonia occurring in a patient after intubation with an endotracheal tube or tracheostomy tube lasting for 48 hours or more
We describe a case of 75-year-old male who initially presented with pneumonia of the right basis with accompanying plevritis
Summary
Ventilator-associated pneumonia (VAP) is a common, possibly life-threatening complication in intensive care unit (ICU) patients with a reported relative risk of 9-27% and mortality of 25-50% [1].The pathogenesis of VAP is supported to initiate from the aspiration of oropharyngeal secretions past the endotracheal tube cuff or from inoculation directly into the airway, resulting in the development of severe inflammationManuscript accepted for publication September 14, 2012We present an extremely rare case of a patient with VAP who developed lung abscess, due to acinetobacter baumanii infection and who was treated with administration of mereponem and colistin combined with computed tomography (CT)-guided drainage. We describe a case of 75-year-old male who initially presented with pneumonia of the right basis with accompanying plevritis. The patient was intubated and his condition was complicated with a VAP infection while he developed a lung abscess.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
